home.aspx
 
EVENTS

THE 2021 CLINICAL DISCLOSURE VIRTUAL
THE 2021 CLINICAL DISCLOSURE VIRTUAL
May 11-12, 2021
Sophisticated and fully interactive conference experience, leverage best practices, networking and on-demand sessions will be available in one place, at the touch of a button.

Discover how Clinical Data Disclosure, Transparency & Plain Language Summaries Virtual Platform will elev...

Pharma Manufacturing Automation 2021
PHARMA MANUFACTURING AUTOMATION 2021
May 18-19, 2021
As the use of the robotics in the pharmaceutical manufacturing industry increases rapidly, it’s important to consider the benefits of the latest technologies for manufacturers, researchers and scientists. The advantages include greater speed and accuracy, more flexibility and more reliability ...

AJA Pharmaceutical Industries Co. Ltd.

SHARESHARESHARE
AJA Pharma has its own state of-the-art manufacturing plant, located in Hail Industrial City of Saudi Arabia. The plant is aimed to provide latest & highest standards of manufacturing services across the region. AJA Pharmaceuticals plant is capable to produce a wide range of pharmaceutical products in various finished dosage forms, thereby catering to the Contract manufacturing needs of our partners globally. We aim in AJA Pharma to enter into collaborations to co-Develop, co-Manufacture, co-Market and to widely sell and distribute carefully selected range of products as well as under license production projects with technology transfer; relying on the huge capabilities, highest quality and unique technologies we have in AJA Pharma Plant including the processing of lyophilized injectables to satisfy the ever-increasing market demands in our region and across the Globe.
SHARESHARESHARE

RELATED NEWS


Sunovion Pharmaceuticals Inc. (Sunovion) today announced that the U.S. Food and Drug Administration (FDA) has accepted for review the New Drug Application (NDA) for dasotraline, a novel dual-acting dopamine and norepinephrine reuptake inhibitor (DNRI) being evaluated for the treatment of attention deficit hyperactivity disorder (ADHD) in children, adolescents, and adults....

READ MORE

As government officials continue to scrutinize the high costs of many drugs, particularly the price of life-saving insulin, Indianapolis-based Eli Lilly disclosed data over the weekend that indicates the price for its lead insulin product Humalog dropped by 8 percent over the past five years. In its disclosure, Eli Lilly said that pricing of medications is one of its biggest and most important decisions. Eli Lilly said that across its product portfolio in the United States, the average net price...

READ MORE

Genpact is investing in leading digital technologies that are transforming industries. Genpact’s Pharmacovigilance Artificial Intelligence (PVAI) will be the life sciences industry’s first fully-integrated, end-to-end adverse event (AE) processing solution, leveraging intelligent automation to not only dramatically reduce the effort of processing adverse events, but also to enable an AI-driven level of real-time predictive analytics and actionable insight not previously possible....

READ MORE

For the first time, patients with a rare and life-threatening blood disorder have a treatment option after Novartis’ Rydapt got an EU licence for aggressive systemic mastocytosis, related blood cancers, and acute myeloid leukaemia....

READ MORE

The SGTC is broadly interested in developing new technologies for biology and medical research that will ultimately improve and reduce the cost of healthcare. My research uses budding yeast as a tool for synthetic biology, and also in chemical and functional genomic applications. We are most interested in developing methods that address difficult problems that aren’t easily addressed by existing technologies....

READ MORE

Grifols, one of the world's three top providers of plasma-derived medicines to treat life-threatening diseases, today announced that its long-term global initiative to providing treatment to people with hemophilia in developing regions has surpassed 100 million international units (IUs) in donated blood clotting factor, a protein in blood that controls bleeding. Grifols is working to enhance the lives of the roughly 100,000 people around the world who have hemophilia but receive little or no...
GRIFOLS
READ MORE

EVENTS

THE 2021 CLINICAL DISCLOSURE VIRTUAL
THE 2021 CLINICAL DISCLOSURE VIRTUAL
May 11-12, 2021
Sophisticated and fully interactive conference experience, leverage best practices, networking and on-demand sessions will be available in one place, at the touch of a button.

Discover how Clinical Data Disclosure, Transparency & Plain Language Summaries Virtual Platform will elev...

Pharma Manufacturing Automation 2021
PHARMA MANUFACTURING AUTOMATION 2021
May 18-19, 2021
As the use of the robotics in the pharmaceutical manufacturing industry increases rapidly, it’s important to consider the benefits of the latest technologies for manufacturers, researchers and scientists. The advantages include greater speed and accuracy, more flexibility and more reliability ...